A CUMC - led study finds that acupuncture can reduce the joint pain caused
by aromatase inhibitors, a drug taken by two - thirds of all breast cancer patients.
They can be prevented
by an aromatase inhibitor which will reduce and inhibit the body to bloat.
Not exact matches
The
aromatase inhibitor is now being tested in a clinical trial in France, led
by Netchine, who has become a close collaborator and friend of Harbison's.
For example, women whose cancer was no longer controlled
by letrozole or other
aromatase inhibitors, those who had already begun to receive chemotherapy, and premenopausal patients with metastatic disease.
Claudine Isaacs, a medical oncologist at Georgetown University's Lombardi Comprehensive Cancer Center, said the data was long - awaited
by clinicians who wondered whether prolonged treatment with
aromatase inhibitors would be beneficial and safe for patients.
Aromatase inhibitors (AIs), in contrast, lower the amount of estrogen in the body
by preventing non-ovary tissues from producing it.